Emergent Presents ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) Historical Safety Data at World Vaccine Congress

April 21, 2025

Emergent BioSolutions will present an overview of historical safety data for ACAM2000® on Thursday, April 24, 2025, at World Vaccine Congress in Washington, D.C.

The presentation will be held at 10:10 am eastern time at the Walter E. Washington Convention Center in room 202B and is available to all World Vaccine Congress conference pass holders.

ACAM2000® is part of Emergent’s medical countermeasures portfolio. To learn more about how Emergent delivers protective and life-saving solutions for health threats like smallpox and mpox, visit emergentbiosolutions.com.

Please see the full Prescribing Information and Medication Guide for ACAM2000® for Boxed Warning and important safety information.

About Emergent BioSolutions:
At Emergent, our mission is to protect and save lives. For over 25 years, we’ve been at work preparing those entrusted with protecting public health. We deliver protective and life-saving solutions for health threats like smallpox, mpox, botulism, Ebola, anthrax and opioid overdose emergencies. To learn more about how we help prepare communities around the world for today’s health challenges and tomorrow’s threats, visit our website and follow us on LinkedIn, X, Instagram, Apple Podcasts and Spotify.

Investor Contact:
Richard S. Lindahl
Executive Vice President, CFO
lindahlr@ebsi.com

Media Contact:
Assal Hellmer
Vice President, Communications
mediarelations@ebsi.com